My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 254

    1.

    Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls.

    Locke I, Kote-Jarai Z, Fackler MJ, Bancroft E, Osin P, Nerurkar A, Izatt L, Pichert G, Gui GP, Eeles RA.

    Breast Cancer Res. 2007;9(1):R20.PMID: 17324252 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers.

    Antill YC, Mitchell G, Johnson SA, Devereux L, Milner A, Di Iulio J, Lindeman GJ, Kirk J, Phillips KA, Campbell IG.

    Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):265-74.PMID: 20056647 [PubMed - indexed for MEDLINE]Related articles

    3.

    Loss of heterozygosity at the BRCA1 and BRCA2 loci detected in ductal lavage fluid from BRCA gene mutation carriers and controls.

    Locke I, Kote-Jarai Z, Bancroft E, Bullock S, Jugurnauth S, Osin P, Nerurkar A, Izatt L, Pichert G, Gui GP, Eeles RA.

    Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1399-402.PMID: 16835343 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis.

    Vasilatos SN, Broadwater G, Barry WT, Baker JC Jr, Lem S, Dietze EC, Bean GR, Bryson AD, Pilie PG, Goldenberg V, Skaar D, Paisie C, Torres-Hernandez A, Grant TL, Wilke LG, Ibarra-Drendall C, Ostrander JH, D'Amato NC, Zalles C, Jirtle R, Weaver VM, Seewaldt VL.

    Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):901-14. Epub 2009 Mar 3.PMID: 19258476 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Methylation not a frequent "second hit" in tumors with germline BRCA mutations.

    Dworkin AM, Spearman AD, Tseng SY, Sweet K, Toland AE.

    Fam Cancer. 2009;8(4):339-46. Epub 2009 Apr 2.PMID: 19340607 [PubMed - indexed for MEDLINE]Related articles

    6.

    DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.

    Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P.

    Int J Cancer. 2003 Dec 20;107(6):970-5.PMID: 14601057 [PubMed - indexed for MEDLINE]Related articles

    7.

    Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation.

    Mitchell G, Antill YC, Murray W, Kirk J, Salisbury E, Lindeman GJ, Di Iulio J, Milner AD, Devereaux L, Phillips KA.

    Breast Cancer Res. 2005;7(6):R1122-31. Epub 2005 Nov 14.PMID: 16457692 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation.

    Krassenstein R, Sauter E, Dulaimi E, Battagli C, Ehya H, Klein-Szanto A, Cairns P.

    Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):28-32.PMID: 14734448 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.

    Kontorovich T, Cohen Y, Nir U, Friedman E.

    Breast Cancer Res Treat. 2009 Jul;116(1):195-200. Epub 2008 Jul 19.PMID: 18642075 [PubMed - indexed for MEDLINE]Related articles

    10.

    Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.

    Potapova A, Hoffman AM, Godwin AK, Al-Saleem T, Cairns P.

    Cancer Res. 2008 Feb 15;68(4):998-1002.PMID: 18281473 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

    Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group.

    J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. Epub 2008 Oct 28.PMID: 18957670 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung.

    Mehrotra J, Vali M, McVeigh M, Kominsky SL, Fackler MJ, Lahti-Domenici J, Polyak K, Sacchi N, Garrett-Mayer E, Argani P, Sukumar S.

    Clin Cancer Res. 2004 May 1;10(9):3104-9.PMID: 15131050 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk.

    Euhus DM, Bu D, Ashfaq R, Xie XJ, Bian A, Leitch AM, Lewis CM.

    Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1812-21.PMID: 17855699 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    BRCA1 promoter methylation predicts adverse ovarian cancer prognosis.

    Chiang JW, Karlan BY, Cass L, Baldwin RL.

    Gynecol Oncol. 2006 Jun;101(3):403-10. Epub 2005 Dec 19.PMID: 16360812 [PubMed - indexed for MEDLINE]Related articles

    15.

    Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?

    Loud JT, Thiébaut AC, Abati AD, Filie AC, Nichols K, Danforth D, Giusti R, Prindiville SA, Greene MH.

    Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1243-51. Epub 2009 Mar 31.PMID: 19336560 [PubMed - indexed for MEDLINE]Related articles

    16.

    Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

    Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.

    Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93.PMID: 15448006 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk.

    Bean GR, Ibarra Drendall C, Goldenberg VK, Baker JC Jr, Troch MM, Paisie C, Wilke LG, Yee L, Marcom PK, Kimler BF, Fabian CJ, Zalles CM, Broadwater G, Scott V, Seewaldt VL.

    Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):50-6.PMID: 17220331 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancer.

    Chen Y, Toland AE, McLennan J, Fridlyand J, Crawford B, Costello JF, Ziegler JL.

    Genet Test. 2006 Winter;10(4):281-4.PMID: 17253935 [PubMed - indexed for MEDLINE]Related articles

    19.

    Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.

    Cavallone L, Arcand SL, Maugard C, Ghadirian P, Mes-Masson AM, Provencher D, Tonin PN.

    BMC Cancer. 2008 Apr 10;8:96.PMID: 18402691 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.

    Higgins SA, Matloff ET, Rimm DL, Dziura J, Haffty BG, King BL.

    Breast Cancer Res. 2005;7(6):R1017-22. Epub 2005 Oct 24.PMID: 16280052 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk